Neurology R&D

Neurodegenerative diseases, such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and amyotrophic lateral sclerosis (ALS), affect millions of people worldwide.

Neurodegenerative diseases occur when nerves in the central nervous system (CNS) lose function over time and die, resulting in a loss of specific brain functions, such as memory, movement, and cognition.

Neuregulins (NRGs) play a key role in developing, maintaining, and repairing the CNS. NRG-1 has shown early promise in treating neurodegenerative diseases and SalubrisBio is currently assessing JK07’s potential as a treatment for several neurodegenerative conditions.